Home/ Supplements/ Tyrosine/ Destress

Destress

product on market Capsule Rae Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

L-Tyrosine, Rhodiola, and GABA are studied for their roles in managing stress and supporting cognitive function. Research providing moderate evidence suggests these ingredients may help modulate the stress response. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Destress
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Proprietary Blend
400 mg
100 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
Market median: 300.0mg (122 products) 22 studies (A:0, B:7)
Gamma-Aminobutyric Acid
50 mg

Other Ingredients

Rice, Powder Hydroxypropylmethylcellulose Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Directions for Use

Suggested use: Take 2 capsules daily

Additional Information

30 day supply

Store in a cool, dry place.

Metadata

Product Details

DSLD Entry Date2023-03-22
Product TypeOther Combinations
FormCapsule
BrandRae
DSLD ID288079
Data Updated2026-04-11
Research

Research Evidence

50
Research Sources
47
Avg Quality
28
Rct
13
Clinical Trial
5
Guideline
4
Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025 PubMed DOI
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025 PubMed DOI
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020 PubMed DOI
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025 PubMed DOI
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025 PubMed DOI
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025 PubMed DOI
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020 PubMed DOI
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023 PubMed DOI
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024 PubMed DOI
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020 PubMed DOI
View all evidence for Tyrosine →
Compare

Similar Products

View all Tyrosine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.